Buck Wealth Strategies’s BioNTech BNTX Stock Holding History

Buck Wealth Strategies’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7	Closed	-$765	–	370
2023 Q2	$765	Hold	7	–	–	﹤0.01%	258
2023 Q1	$883	Buy	+7	New	+$961	﹤0.01%	193

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Buck Wealth Strategies's BNTX Position: Q3 2023 in Review

Buck Wealth Strategies sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 7 shares — an estimated $765 sold.

Buck Wealth Strategies first reported a position in BNTX in Q1 2023 and held it in 2 quarters. The position peaked at $883 in Q1 2023. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Buck Wealth Strategies reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Buck Wealth Strategies sold 7 BioNTech shares in Q3 2023, an estimated $765.
Buck Wealth Strategies first reported a position in BioNTech in Q1 2023 and held it in 2 quarters.
Buck Wealth Strategies's BioNTech position peaked at $883 in Q1 2023.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Buck Wealth Strategies's 13F filing for Q3 2023, filed 6 Nov 2023.